Tuesday, August 18, 2026 SourcesAbout🌓
🇨🇦 CA ▾
BREAKING
OpenAI says new ChatGPT designed for teens aims to be more age-appropriate HydroGraph Announces Upsize of Previously Announced Bought Deal Offering to C$61 Million Nightfood Holdings Inc. (OTCQB: NGTF) Announces Key LOI, Strengthens Position in AI Robotics Space Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration CloudWerx Names Ahmed Shama as Chief Executive Officer to Lead Next Phase of Growth 2 dead in livestreamed Philippine school attack, second in two months Take a bough: Climbing takes relationship with B.C.’s trees to the next level Historical context behind Blue Jays’ wild-card push in weak American League B.C.’s provincial health officer to hold news conference amid wildfire smoke warnings Penhall Subsurface, a Premier Provider of Utility Locating and Mapping Services, Adopts ProStar’s PointMan Enterprise Platform OpenAI says new ChatGPT designed for teens aims to be more age-appropriate HydroGraph Announces Upsize of Previously Announced Bought Deal Offering to C$61 Million Nightfood Holdings Inc. (OTCQB: NGTF) Announces Key LOI, Strengthens Position in AI Robotics Space Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration CloudWerx Names Ahmed Shama as Chief Executive Officer to Lead Next Phase of Growth 2 dead in livestreamed Philippine school attack, second in two months Take a bough: Climbing takes relationship with B.C.’s trees to the next level Historical context behind Blue Jays’ wild-card push in weak American League B.C.’s provincial health officer to hold news conference amid wildfire smoke warnings Penhall Subsurface, a Premier Provider of Utility Locating and Mapping Services, Adopts ProStar’s PointMan Enterprise Platform
Business

Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board

Financial Post ·

Former Intra-Cellular Therapies, Inc. (“Intra-Cellular”) executives bring complementary experience in organizational scale-up, central nervous system (“CNS”) drug development, regulatory approvals and commercialization M

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

More from Financial Post

See all ›

More in Business

See all ›